FDA inspection
Apotex Research Private Limited: FDA inspection ending Dec 13, 2024
FDA inspection 1265748 · Voluntary Action Indicated (VAI) · Bangalore
Key facts
| Inspection ID | 1265748 |
|---|---|
| Firm | Apotex Research Private Limited |
| FEI number | 3007078919 |
| Address | Bioequivalence Centre, Site No. 1 & 2, Bommasandra Industrial Area, 4th Phase, Jigani Link Road |
| City | Bangalore |
| Country | India |
| Fiscal year | 2025 |
| Inspection end date | Dec 13, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data